November 12, 2004
Genelabs Technologies to Present at the SG Cowen 5th Annual Global Health Care Conference

November 11, 2004
GENELABS RECEIVES MILESTONE PAYMENT
FROM GLAXOSMITHKLINE RELATING TO HEV VACCINE

November 4, 2004
GENELABS TECHNOLOGIES, INC. REPORTS FINANCIAL RESULTS
FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2004
AND PROVIDES COMPANY UPDATE

October 21, 2004
Genelabs Technologies to Present at the
Rodman & Renshaw Techvest 6th Annual Healthcare Conference

October 5, 2004
GENELABS ANNOUNCES PRELIMINARY RESULTS OF CLINICAL TRIAL GL02-01 IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS - Study Fails to Meet Primary Endpoint

September 30, 2004
Gilead and Genelabs Announce Research Collaboration and License Agreement for the Development of Genelabs' Novel Hepatitis C Compounds

September 9, 2004
GENELABS ANNOUNCES PUBLICATION OF PRESTARA™ GL95-02 CLINICAL TRIAL RESULTS FOR WOMEN WITH LUPUS

August 13, 2004
GENELABS TECHNOLOGIES ANNOUNCES COMPLETION OF PRESTARA™ CLINICAL TRIAL GL02-01 FOR WOMEN WITH LUPUS

August 3, 2004
GENELABS TECHNOLOGIES, INC. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2004

June 23, 2004
Genelabs Technologies Appoints Adrian Arima As Vice President, General Counsel

June 7, 2004
Genelabs Technologies Announces Decision to Withdraw European Marketing Application for Anastar™

May 17, 2004
Genelabs Technologies to Present at the Banc of America Securities Healthcare Conference

May 10, 2004
GENELABS TECHNOLOGIES, INC. REPORTS 2004 FIRST QUARTER FINANCIAL RESULTS

May 7, 2004
GENELABS PRESENTS HEPATITIS C VIRUS DRUG DISCOVERY DATA AT INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

May 6, 2004
GENELABS TECHNOLOGIES PARTICIPATES IN 7TH INTERNATIONAL CONGRESS ON SLE AND RELATED CONDITIONS

May 3, 2004
Genelabs Technologies to Present at the Rodman & Renshaw Techvest Global Healthcare Conference

April 21, 2004
GENELABS TECHNOLOGIES COMPLETES SALE OF DIAGNOSTICS BUSINESS

March 15, 2004
Genelabs Technologies Reports 2003 Year-End and Fourth Quarter Financial Results

March 8, 2004
Genelabs Technologies to Present at SG Cowen Health Care Conference

February 13, 2004
GENELABS TECHNOLOGIES ANNOUNCES THAT DR. IRENE CHOW RETIRES FROM FULL-TIME CEO RESPONSIBILITIES WHILE REMAINING CHAIRMAN OF THE BOARD JAMES A.D. SMITH APPOINTED AS CEO

February 9, 2004
Genelabs Technologies Completes Enrollment
in Confirmatory Phase III Clinical Trial of Prestara™ for Lupus

January 28, 2004
GENELABS TECHNOLOGIES AND TANABE SEIYAKU ENTER INTO COLLABORATION AND LICENSE AGREEMENT FOR LUPUS DRUG IN JAPAN

© Genelabs Technologies, Inc. All rights reserved. - Terms of Use